Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster
  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Indian Markets Trade Flat
Thu, 31 Mar 01:30 pm

After opening the day on a firm note, the Indian Markets lost their momentum and went on to trade near the dotted line in the post-noon trading session. Sectoral indices are trading on a mixed note with stocks from the power and FMCG sectors leading the gains. Oil & gas stocks are trading in the red.

The BSE Sensex is trading up by 48 points (up 0.2%) and the NSE Nifty is trading up by 11 points (up 0.1%). The BSE Mid Cap index and the BSE Small Cap index are also trading positively, up by 0.1% and 0.3% respectively. The rupee is trading at 66.29 to the US$.

Gold prices, per 10 grams, are trading at Rs 28,485 levels. Silver price, per kilogram is trading at Rs 36,422 levels.

Crude oil is trading at Rs 2,517 per barrel. Reportedly, crude oil future contracts are witnessing selling pressure amid worries of global supply glut. There are growing concerns after official data showed that US crude inventories rose to a record last week for the seventh time in a row. Moreover, these concerns are fueled with the rising output from the Organisation of the Petroleum Exporting Countries (OPEC). It should be noted that in order to resolve these concerns, OPEC and non-OPEC producers including the top two exporters, Saudi Arabia and Russia, are going to hold talks on April 17 in Qatar over a plan to freeze output. To keep a regular tab on the movements in crude oil prices, you can read weekly updates from the Daily Profit Hunter team here. Their roundup tracks the developments in the global economy as well as currency and commodity markets.

Stocks in the paints sector are trading on a mixed note with Berger Paints and Kansai Nerolac leading the gains. As per a leading financial daily, Asian Paints has entered into the retail segment of the adhesives category. This development comes after the company entered into a distribution arrangement with Germany's Henkel Adhesive Technologies.

As per the arrangement, Asian Paints will sell Henkel's adhesive brand - 'Loctite' at the retail level through a co-branding initiative.

The company stated that it has already begun efforts to woo retail customers through an ad campaign. Also, the company is presently selling Loctite in certain markets in western India.

Asian Paints is India's largest paint company and Asia's third largest paint company. The company along with its subsidiaries has operations in 20 countries across the world, servicing consumers in 65 countries. The company has a distribution network spanning 36,000 hardware shops. Presently its scrip is trading down by 1.1%.

Stocks in the pharmaceuticals space are trading on a mixed note with Novartis and Sanofi India leading the gains.

In another news update it was reported that GlaxoSmithKline Pharmaceuticals is looking at launching two or three combination vaccines in India in the near future. These launches are planned to address a host of paediatric disease. Further, the company is also organizing programmes to spread awareness about the need of vaccination among public.

The company is expected to launch a four-antigen, a five-antigen and a six-antigen combination to cover several disease in a single vaccine. Various paediatric disease vaccinations including diphtheria, pertussis (whooping cough), and tetanus (DPT), Hepatitis B and Polio are to be addressed through these combinations.

The company has already finished clinical trials for these launches and is now awaiting regulatory approval for the same (subscription required).

In the context of regulatory approvals and healthcare regulations, one shall note that the Indian Health Ministry has recently announced a ban on 344 fixed dosage combination (FDC) drugs. FDC drugs are developed using two or more different active pharmaceutical ingredients (APIs) in a single pill. The pharma companies will have to suspend the manufacturing and sale of these 344 drugs, including cough syrups, analgesics, and antibiotic combinations. In one of our editions of The 5 Minute WrapUp Premium, we have explained how the ban poses a new challenge for the pharma companies (subscription required).

GlaxoSmithKline Pharmaceuticals is one of the world's leading research-based pharmaceutical and healthcare companies. Presently the stock of the company is trading down by 0.3%.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

Equitymaster requests your view! Post a comment on "Indian Markets Trade Flat". Click here!


Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms


Mar 16, 2018 (Close)